Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™
BioSeeker mapped more than 10,000 isolates and identified targetable regions that provide 100% strain coverage across the viral family. […]
About:Press Release
Posts by Press Release :
Biolexis Therapeutics Initiates First-in-Human Clinical Trials for Novel, Oral Muscle-Sparing, Weight Loss and Type 2 Diabetes Therapies
Biolexis Therapeutics Initiates First-in-Human Clinical Trials for Novel, Oral Muscle-Sparing, Weight Loss and Type 2 Diabetes Therapies […]
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Atopic Dermatitis in Children Ages 2 to 5 […]
2025 MedTech Conference Sponsored by AdvaMed
This week AdvaMed held its annual Medtech Conference, designed for those in the medical technology industry. […]
Nelson Labs’ 40th Anniversary Celebration Recap
Nelson Labs on October 1 celebrated a milestone 40th anniversary. Since its humble beginnings in 1985 in University of Utah’s Research Park, Nelson Labs has grown into a trusted, global leader of medical device and pharmaceutical testing. […]
Glafabra Therapeutics, Uncommon Cures Collaborate to Advance Fabry Disease Therapy
Glafabra Therapeutics, Uncommon Cures Collaborate to Advance Fabry Disease Therapy […]
Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network, Rapid Response Partnership Vehicle
Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV) […]
Innovative Wearable for Pelvic Floor Health by Freyya Completes Clinical Study
Innovative Wearable for Pelvic Floor Health by Freyya Completes Clinical Study […]
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy […]
Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East
The Memorandum of Understanding includes the formation of a Joint Venture in the Kingdom of Saudi Arabia for manufacturing and distribution of the Company’s upcoming Co-Dx™ PCR platform and other Co-Dx IP […]
Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease
Definitive agreement to accelerate adoption of Renalytix’s FDA-approved, Medicare reimbursed kidneyintelX.dkd test to slow kidney disease progression and improve patient outcomes […]
KUDA THERAPEUTICS AWARDED $5.6M U.S. DoD GRANT TO BRING LEAD ONCOLOGY CANDIDATE INTO CLINIC
KUDA THERAPEUTICS AWARDED $5.6M U.S. DoD GRANT TO BRING LEAD ONCOLOGY CANDIDATE INTO CLINIC […]